Pharma Mar, S.A. (PHMMF)

Pharma Mar Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	175.75	174.86	158.15	196.34	229.83	269.96
Revenue Growth (YoY)	8.39%	10.56%	-19.45%	-14.57%	-14.87%	214.57%
Cost of Revenue	9.82	8.18	9.61	13.64	16.44	13.72
Gross Profit	165.93	166.67	148.54	182.7	213.39	256.24
Selling, General & Admin	49.9	47.18	41.81	43.24	39.74	35.77
Research & Development	97.6	103.5	99.3	83.45	72.17	53.79
Other Operating Expenses	10.75	9.52	11.26	13.94	9.04	9.77
Operating Expenses	158.25	160.2	152.37	140.63	120.95	99.6
Operating Income	7.68	6.47	-3.83	42.07	92.45	156.64
Interest Expense	-3.29	-2.47	-2.42	-2.38	-3.37	-3.12
Interest & Investment Income	5.68	5.68	4.32	0.88	0.37	0.34
Currency Exchange Gain (Loss)	2.31	2.31	-1.68	3.11	5.67	-7.55
Other Non Operating Income (Expenses)	-1.53	-	-	-	-	-
EBT Excluding Unusual Items	10.85	11.99	-3.61	43.68	95.12	146.31
Gain (Loss) on Sale of Investments	-	-	-0.02	-1.89	0.01	-0.7
Other Unusual Items	-	-	-	2	-	-
Pretax Income	10.85	11.99	-3.62	43.79	95.13	145.61
Income Tax Expense	-9.03	-14.14	-4.76	-5.57	2.27	8.34
Earnings From Continuing Operations	19.88	26.13	1.14	49.36	92.86	137.26
Net Income to Company	19.88	26.13	1.14	49.36	92.86	137.26
Net Income	19.88	26.13	1.14	49.36	92.86	137.26
Net Income to Common	19.88	26.13	1.14	49.36	92.86	137.26
Net Income Growth	881.05%	2197.71%	-97.70%	-46.85%	-32.35%	-
Shares Outstanding (Basic)	-	18	18	18	18	18
Shares Outstanding (Diluted)	-	18	18	18	18	18
Shares Change (YoY)	-	-1.98%	-0.81%	-0.12%	-1.31%	-0.77%
EPS (Basic)	-	1.49	0.06	2.73	5.14	7.50
EPS (Diluted)	-	1.49	0.06	2.73	5.13	7.49
EPS Growth	-	2382.56%	-97.80%	-46.78%	-31.51%	-
Free Cash Flow	-17.79	-8.99	-28.25	29.47	17.87	275.94
Free Cash Flow Per Share	-	-0.51	-1.58	1.63	0.99	15.06
Dividend Per Share	0.800	0.800	0.650	0.650	0.650	0.600
Dividend Growth	23.08%	23.08%	-	-	8.33%	25.00%
Gross Margin	94.41%	95.32%	93.92%	93.05%	92.85%	94.92%
Operating Margin	4.37%	3.70%	-2.42%	21.43%	40.22%	58.03%
Profit Margin	11.31%	14.94%	0.72%	25.14%	40.40%	50.84%
Free Cash Flow Margin	-10.12%	-5.14%	-17.87%	15.01%	7.78%	102.21%
EBITDA	11.73	10.07	-1.15	44.88	94.99	159.09
EBITDA Margin	6.67%	5.76%	-0.73%	22.86%	41.33%	58.93%
D&A For EBITDA	4.04	3.6	2.68	2.81	2.54	2.45
EBIT	7.68	6.47	-3.83	42.07	92.45	156.64
EBIT Margin	4.37%	3.70%	-2.42%	21.43%	40.22%	58.03%
Effective Tax Rate	-	-	-	-	2.39%	5.73%
Revenue as Reported	175.75	174.86	158.15	196.34	229.83	269.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.